Article
Health-Related Quality of Life in 91 Patients with X-Linked Agammaglobulinemia.
Journal of clinical immunology - 1 May 2022
Altman Katherine, Zhou Chuan, Hernandez-Trujillo Vivian, Scalchunes Christopher, Rawlings David J, de la Morena M Teresa
Abstract excerpt
PURPOSE: X-linked agammaglobulinemia (XLA) is a primary immunodeficiency (PID) caused by a defect in the gene encoding for Bruton tyrosine kinase (BTK). In the absence of a functional BTK, patients have low or absent circulating B cells and low or absent serum immunoglobulin. Despite gammaglobulin replacement and prompt use of antimicrobial agents, patients with XLA continue to experience infectious and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
